louisiana semaglutide diarrhea class action Lawsuit filed against makers of Ozempic, Mounjaro over claims of 'gastrointestinal side effects' Rybelsus Lawsuit - Shreveport Lawyer
Description
Accessed 15 Jun 2025
First cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk
The generally accepted dosage of methylene blue drops is 10 (5 mg) to 40 (20 mg) drops daily
Body positivity and self-acceptance are gaining ground
Additionally, the BMI was lower by at least 5% in 77% of children receiving semaglutide compared to 20% receiving a placebo
The anticipation is almost always worse than the reality
